A new method is described for identifying low concentrations of circulating derivatives of
fibrinogen and fibrin, even when present in heterogeneous mixtures. This technique is …

A method and reagent for determining fibrinogen from undiluted plasma samples. The use of
undiluted plasma as sample is made possible by the use of a specific peptide inhibitor of …

Fibrinogen degradation, fibrin polymerisation, and the insertion of cross links into fibrin by
fibrin stabilising factor lead to the appearance of new antigenic determinants. Antibodies …

This invention relates to an assay for fibrin polymers for use in the diagnosis of patients at
risk of thrombosis and in monitoring the effects of treatment in such patients. More …

Systemic coagulation activation can be triggered by a variety of mechanisms, leading to the
disseminated intravascular coagulation syndrome. 28, 29 Since coagulation activation takes …

A technique has been developed to identify and quantitate unique plasmic degradation
products of crosslinked fibrin in plasma. In this method, fibrin derivatives are extracted by …

57 ABSTRACT A monoclonal antibody that reacts with a human Soluble fibrin but not with a
human fibrinogen; a hybridoma that Secretes the above antibody; and a method of assaying …

The ability to identify the products of thrombin and plasmin action on fibrinogen is important
in patients with thrombotic and fibrinolytic disorders. New assays have been developed for …

The ability of the COA-SET Fibrin monomer (COA-SET FM) test to detect soluble fibrin was
evaluated by comparing the results of the COA-SET FM test with fibrino-peptide A (FPA) …

An in vitro immunoassay to detect and quantitate soluble crosslinked and non-crosslinked
DesAABB? brin polymers in a sample from a subject. The assay can be used to support a …